Regeneron Pharmaceuticals ceo salary

Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer of REGENERON PHARMACEUTICALS, INC. (REGN), received $7,280,549 ($7.3M) in total compensation for FY2025. Non-equity incentive compensation of $3,682,655 was the largest component. Figures come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).

Reported total from the latest DEF 14A pay table. Source filing (accession 0001308179-26-000340). These figures come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).

Component	Amount
Salary	$1,979,922
Cash incentive	$3,682,655
Other	$1,617,972
Total	$7,280,549

FAQ

Common questions

How much does the Regeneron Pharmaceuticals CEO make?: Leonard S. Schleifer received $7,280,549 in total compensation for FY2025 as M.D., Ph.D. Board co-Chair, President and Chief Executive Officer of REGENERON PHARMACEUTICALS, INC. (REGN), per REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).
Where does this number come from?: The numbers come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).

Regeneron Pharmaceuticals ceo salary

Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer of REGENERON PHARMACEUTICALS, INC. (REGN), received $7,280,549 ($7.3M) in total compensation for FY2025. Non-equity incentive compensation of $3,682,655 was the largest component. Figures come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).

Reported total from the latest DEF 14A pay table. Source filing (accession 0001308179-26-000340). These figures come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).

Component	Amount
Salary	$1,979,922
Cash incentive	$3,682,655
Other	$1,617,972
Total	$7,280,549

FAQ

Common questions

How much does the Regeneron Pharmaceuticals CEO make?: Leonard S. Schleifer received $7,280,549 in total compensation for FY2025 as M.D., Ph.D. Board co-Chair, President and Chief Executive Officer of REGENERON PHARMACEUTICALS, INC. (REGN), per REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).
Where does this number come from?: The numbers come from REGENERON PHARMACEUTICALS, INC.'s DEF 14A filed 24 Apr 2026 (accession 0001308179-26-000340).